These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33156542)

  • 1. Monitoring for the metabolic side effects of second-generation antipsychotic medications: Psychiatrists' views and practices.
    Abdulhaq B; Dardas LA; Sami O
    Perspect Psychiatr Care; 2021 Jul; 57(3):1237-1243. PubMed ID: 33156542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists.
    Walter G; DeLaroche A; Soh N; Hunt G; Cleary M; Malhi G; Lambert T; Correll C; Rey J
    Australas Psychiatry; 2008 Aug; 16(4):253-62. PubMed ID: 18608172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists.
    Aguglia A; Serafini G; Nebbia J; Salvi V; Martinotti G; Corbo M; Signorelli MS; Mineo L; Mencacci C; Di Sciascio G; Biggio G; Aguglia E; Amore M
    J Pers Disord; 2021 Jun; 35(3):321-335. PubMed ID: 31609189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
    Sugawara N; Yasui-Furukori N; Yamazaki M; Shimoda K; Mori T; Sugai T; Suzuki Y; Someya T
    PLoS One; 2014; 9(1):e86826. PubMed ID: 24466260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To examine the extent of compliance to the proposed monitoring protocol among practicing psychiatrists for second generation antipsychotics.
    Khan AY; Shaikh MR; Ablah E
    J Pak Med Assoc; 2010 Jun; 60(6):446-50. PubMed ID: 20527641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
    Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
    Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics.
    Rodday AM; Parsons SK; Mankiw C; Correll CU; Robb AS; Zima BT; Saunders TS; Leslie LK
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):351-61. PubMed ID: 25918843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics.
    Mangurian C; Giwa A; Brosey E; Shumway M; Dilley J; Fuentes-Afflick E; Pérez-Stable EJ; Schillinger D
    J Am Board Fam Med; 2019; 32(3):418-423. PubMed ID: 31068407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability.
    Teeluckdharry S; Sharma S; O'Rourke E; Tharian P; Gondalekar A; Nainar F; Roy M
    J Intellect Disabil; 2013 Sep; 17(3):223-35. PubMed ID: 23801356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic prescription assessment in general practice: metabolic effects].
    Gignoux-Froment F; de Montleau F; Saravane D; Verret C
    Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Monitoring of Child and Adolescent Patients on Atypical Antipsychotics by Psychiatrists and Primary Care Providers.
    Wakefield S; Aligeti M; Rachamallu V; Baronia R; Aynampudi R; Parmar A; Peterson P; Masodkar K
    Am J Ther; 2020; 27(5):e425-e430. PubMed ID: 30762589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics.
    Cohen S; Bostwick JR; Marshall VD; Kruse K; Dalack GW; Patel P
    J Clin Pharm Ther; 2020 Dec; 45(6):1398-1404. PubMed ID: 32767599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practitioners' Perspective on Metabolic Monitoring of Second-Generation Antipsychotics: Existing Gaps in Knowledge, Barriers to Monitoring, and Strategies.
    Aouira N; Khan S; Heussler H; Haywood A; Karaksha A; Bor W
    J Child Adolesc Psychopharmacol; 2022 Jun; 32(5):296-303. PubMed ID: 35666251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.